Irvine, CA, United States of America

Phygen, LLC


USPTO Granted Patents = 10

% Expired Patents = 40.0

Forward Citations = 303

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Laszlo Garamszegi (6 out of 21 patents)

silverMedal Bryan Okamoto (2 out of 3 patents)

bronzeMedal Souhail Toubia (1 out of 8 patents)

4.  Steven Keith Isvik (1 out of 3 patents)

5.  Steven J Olson (1 out of 10 patents)

6.  Jami McLaren (1 out of 5 patents)

7.  John Carlisle Brown (1 out of 2 patents)

8.  Igor A Soloshenko (1 out of 1 patent)

9.  Vyacheslav V Tsiolko (1 out of 1 patent)

10.  Vladimir A Khomich (1 out of 1 patent)

11.  Viktor N Khominich (1 out of 1 patent)


10 patents:

Company Overview
Phygen, LLC is a biotechnology company based in Irvine, California, specializing in the development of innovative solutions for the healthcare sector. The organization focuses on advanced genetic technologies and molecular diagnostics, aiming to enhance patient outcomes through precision medicine. By leveraging cutting-edge research and development, Phygen is dedicated to creating tools that facilitate better understanding and treatment of various medical conditions, positioning itself at the forefront of the evolving biotech landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Phygen, LLC USPTO Patent Assignee Logo
10 Patents

#281 in Irvine, CA

#7,114 in California

#29,866 in US

#56,047 in the World

Irvine, CA (US)
Irvine, CA, United States of America
Forward Citations = 303

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Phygen, LLC. Retrieved from https://idiyas.com/company/phygen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…